Elan announces offering price

Pharmaceutical company Elan today announced the pricing of the offering of $1.15bn (€892m) aggregate principal amount of senior notes by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp.

Pharmaceutical company Elan today announced the pricing of the offering of $1.15bn (€892m) aggregate principal amount of senior notes by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp.

Elan increased the size of the offering from the $850m (€659m) aggregate principal amount previously announced.

You have reached your article limit. Already a subscriber? Sign in

185 years of the Irish Examiner

185th
Anniversary Offer

Six months of digital access for €18.50

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited